Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

WhyQuit, an organization that advocates quitting smoking using the cold turkey method, recently published an article that takes Pfizer to task over its latest Chantix ads. The group claims that the pharmaceutical company’s new television commercials hide information from the viewer – information that, if known, would likely dissuade most smokers from using the drug as a smoking cessation aid.

Read the rest of this entry »

Smoking cessation today isn’t as simple as it used to be. Years ago, smokers had a couple of choices: cold turkey or hypnotherapy. Then, as awareness about the dangers of smoking grew, thanks to efforts by the government and independent health groups, so too did the number of smoking cessation aids. First came prescription-only nicotine gum, which was quickly succeeded by a procession-soon-to-be-explosion of over-the-counter therapeutic nicotine — gum, patches, lozenges. In 1997, the FDA approved bupropion (a.k.a. Zyban/Wellbutrin) for use in smoking cessation. Meanwhile, all sorts of gadgets and gimmicks flooded the market. And then came Chantix.

Read the rest of this entry »